Yael Mauer, MD, MPH, discusses the patient population who benefits most from interventions with glucagon-like peptide-1 (GLP-1) therapies and explores the underlying mechanisms at work.
Related Keywords
United States , American , Yael Mauer , Institute For Value , Department Of Endocrinology , Value Based Medicine , Cleveland Clinic , American Journal ,
comparemela.com © 2020. All Rights Reserved.